Repligen Corp (NASDAQ: RGEN) has reported E.P.S. of $-0.60 for its fourth fiscal quarter (ending December 31) versus $-0.29 for the same period a year ago — an increase of 107%. For the latest four quarters through December 31, E.P.S. were $-0.46 versus $0.64 for the same period a year ago — a decline of -172%.
Recent Price Action
On 2/20/25, Repligen Corp (NASDAQ: RGEN) stock enjoyed a very large increase of 7.9%, closing at $162.67. Moreover, exceptionally high trading volume at 308% of normal accompanied the advance. Relative to the market the stock has been strong over the last nine months and has risen 8.8% during the last week.
Current PriceTarget Research Rating
Repligen has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing inconsistent signals. Repligen has a neutral Power Rating of 49 but a poor Appreciation Score of 22, triggering the Negative Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment